Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bonner

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Headache|August 28, 2020
The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% ResponseGregor Broessner, Uwe Reuter, Jo H Bonner, et al.
Environmental Management|June 21, 2015
Can Species Distribution Models Aid Bioassessment when Reference Sites are Lacking? Tests Based on Freshwater FishesBen J Labay, Dean A Hendrickson, Adam E Cohen, et al.
Integrative and Comparative Biology|January 13, 2022
Coping With Urban Habitats Via Glucocorticoid Regulation: Physiology, Behavior, and Life History in Stream FishesArseniy M Kolonin, Veronika Bókony, Timothy H Bonner, et al.
The New England Journal of Medicine|November 25, 2017
A Controlled Trial of Erenumab for Episodic MigrainePeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.
The New England Journal of Medicine|November 30, 1972
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapyJ C Arseneau, R W Sponzo, D L Levin, et al.
The Journal of Headache and Pain|July 24, 2021
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trialsStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
American Journal of Lifestyle Medicine|October 28, 2024
Predictors of Progressing Toward Lifestyle Change Among Participants of an Interprofessional Lifestyle Medicine ProgramAbby L Cheng, Mollie E Dwivedi, Adriana Martin, et al.
Neurology|July 9, 2020
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE studyPeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Headache|August 28, 2020
The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% ResponseGregor Broessner, Uwe Reuter, Jo H Bonner, et al.
Environmental Management|June 21, 2015
Can Species Distribution Models Aid Bioassessment when Reference Sites are Lacking? Tests Based on Freshwater FishesBen J Labay, Dean A Hendrickson, Adam E Cohen, et al.
Integrative and Comparative Biology|January 13, 2022
Coping With Urban Habitats Via Glucocorticoid Regulation: Physiology, Behavior, and Life History in Stream FishesArseniy M Kolonin, Veronika Bókony, Timothy H Bonner, et al.
The New England Journal of Medicine|November 25, 2017
A Controlled Trial of Erenumab for Episodic MigrainePeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.
The New England Journal of Medicine|November 30, 1972
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapyJ C Arseneau, R W Sponzo, D L Levin, et al.
The Journal of Headache and Pain|July 24, 2021
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trialsStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
American Journal of Lifestyle Medicine|October 28, 2024
Predictors of Progressing Toward Lifestyle Change Among Participants of an Interprofessional Lifestyle Medicine ProgramAbby L Cheng, Mollie E Dwivedi, Adriana Martin, et al.
Neurology|July 9, 2020
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE studyPeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.
Pageof 7